For the twelve months ended Jun 30, 2026, Embecta Corp. reported $1.02B of revenue and $87.50M of net income.
EMBC revenue was $271.70M in fiscal Q3 2026 (ended Jun 30, 2026), down 8.1% from a year earlier and up 22.5% from the prior quarter. For the full fiscal 2025 it was $1.08B, down 3.8% from fiscal 2024. Compound annual growth was -0.1% over 5 years. It rose in 2 of the last 5 fiscal years.
EMBC net income was $21.10M in fiscal Q3 2026 (ended Jun 30, 2026), down 53.6% from a year earlier. For the full fiscal 2025 it was $95.40M, up 21.8% from fiscal 2024. Compound annual growth was -25.9% over 5 years. It rose in 2 of the last 5 fiscal years.
EMBC diluted EPS was $0.36 in fiscal Q3 2026 (ended Jun 30, 2026), down 53.8% from a year earlier. For the full fiscal 2025 it was $1.62, up 20.9% from fiscal 2024. Compound annual growth was -26.4% over 5 years.
EMBC free cash flow was $40.70M in fiscal Q3 2026 (ended Jun 30, 2026), down 49.6% from a year earlier and up 33.0% from the prior quarter. For the full fiscal 2025 it was $182.40M, up 816.6% from fiscal 2024. Compound annual growth was -16.8% over 5 years. It rose in 1 of the last 5 fiscal years.
| Line item | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.08B | $1.12B | $1.12B | $1.13B | $1.17B | $1.09B |
| Cost of revenue | $403.60M | $387.90M | $370.90M | $354.60M | $364.90M | $322.90M |
| Gross profit | $676.80M | $735.20M | $749.90M | $774.90M | $800.40M | $762.60M |
| Research and development | $37.30M | $78.80M | $85.20M | $66.90M | $63.30M | $61.40M |
| Selling, general and admin | $332.00M | $365.10M | $341.30M | $294.80M | $240.30M | $214.70M |
| Operating income | $242.10M | $166.80M | $221.50M | $309.60M | $492.00M | $486.50M |
| Pre-tax income | $136.30M | $44.20M | $105.70M | $256.60M | $494.90M | $485.80M |
| Income tax | $40.90M | -$34.10M | $35.30M | $33.00M | $80.10M | $58.20M |
| Net income | $95.40M | $78.30M | $70.40M | $223.60M | $414.80M | $427.60M |
| EPS, basic | $1.64 | $1.36 | $1.23 | $3.92 | $7.28 | $7.50 |
| EPS, diluted | $1.62 | $1.34 | $1.22 | $3.89 | $7.28 | $7.50 |
| Diluted shares | 58.9M | 58.3M | 57.8M | 57.5M | 57.0M | 57.0M |
| Line item | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $225.50M | $274.20M | $326.50M | $330.90M | $0 | $0 |
| Receivables | $145.60M | $193.00M | $16.70M | $22.20M | $150.60M | - |
| Inventory | $178.60M | $171.50M | $152.10M | $122.80M | $118.00M | - |
| Current assets | $631.40M | $761.00M | $749.10M | $664.70M | $291.80M | - |
| Goodwill | $15.40M | $15.60M | $15.60M | $15.70M | $15.60M | - |
| Total assets | $1.09B | $1.29B | $1.21B | $1.09B | $788.00M | - |
| Current liabilities | $261.50M | $374.00M | $353.50M | $301.00M | $164.00M | - |
| Short-term debt | $9.50M | $9.50M | $9.50M | $9.50M | $0 | - |
| Long-term debt | $1.39B | $1.57B | $1.59B | $1.60B | $0 | - |
| Total debt | $1.40B | $1.57B | $1.60B | $1.61B | $0 | $0 |
| Shareholders' equity | -$650.60M | -$738.30M | -$821.70M | -$891.40M | $594.30M | $572.20M |
| Line item | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $191.70M | $35.70M | $67.70M | $412.20M | $456.30M | $498.50M |
| Capital expenditures | $9.30M | $15.80M | $26.50M | $23.60M | $36.80M | $41.90M |
| Free cash flow | $182.40M | $19.90M | $41.20M | $388.60M | $419.50M | $456.60M |
| Investing cash flow | -$9.30M | -$15.80M | -$26.50M | -$24.00M | -$39.20M | -$41.90M |
| Financing cash flow | -$226.70M | -$73.40M | -$48.70M | -$48.00M | -$417.10M | -$456.60M |
| Dividends paid | $35.00M | $34.50M | $34.40M | $8.60M | $0 | $0 |
| Stock-based compensation | $31.60M | $26.30M | $21.50M | $18.70M | $12.80M | $12.70M |
| Depreciation and amortization | $40.70M | $36.20M | $32.60M | $31.70M | $38.30M | $38.30M |
| Line item | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 |
|---|---|---|---|---|---|---|
| Revenue growth, YoY | -3.8% | 0.2% | -0.8% | -3.1% | 7.4% | - |
| Net income growth, YoY | 21.8% | 11.2% | -68.5% | -46.1% | -3.0% | - |
| EPS growth, YoY | 20.9% | 9.8% | -68.6% | -46.6% | -2.9% | - |
| Gross margin | 62.6% | 65.5% | 66.9% | 68.6% | 68.7% | 70.3% |
| Operating margin | 22.4% | 14.9% | 19.8% | 27.4% | 42.2% | 44.8% |
| Net margin | 8.8% | 7.0% | 6.3% | 19.8% | 35.6% | 39.4% |
| Free cash flow margin | 16.9% | 1.8% | 3.7% | 34.4% | 36.0% | 42.1% |
| Return on equity | - | - | - | - | 69.8% | 74.7% |
| Return on assets | 8.7% | 6.1% | 5.8% | 20.6% | 52.6% | - |
| Current ratio | 2.41 | 2.03 | 2.12 | 2.21 | 1.78 | - |
| Debt to equity | - | - | - | - | 0.00 | 0.00 |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $271.70M | $221.80M | $261.20M | $264.00M | $295.50M | $259.00M | $261.90M | $286.10M | $272.50M | $287.20M | $277.30M | $281.90M |
| Cost of revenue | $118.40M | $94.00M | $99.50M | $105.50M | $98.40M | $94.90M | $104.80M | $112.30M | $82.40M | $101.80M | $91.40M | $100.10M |
| Gross profit | $153.30M | $127.80M | $161.70M | $158.50M | $197.10M | $164.10M | $157.10M | $173.80M | $190.10M | $185.40M | $185.90M | $181.80M |
| Research and development | $5.60M | $5.40M | $4.60M | $4.60M | $4.40M | $8.00M | $20.30M | $19.80M | $20.40M | $18.40M | $20.20M | $23.60M |
| Selling, general and admin | $78.60M | $76.20M | $77.60M | $86.90M | $84.40M | $79.60M | $81.10M | $96.80M | $85.70M | $92.30M | $90.30M | $95.70M |
| Operating income | $48.70M | $35.00M | $83.30M | $56.50M | $94.00M | $62.90M | $28.70M | $26.20M | $55.90M | $39.20M | $45.50M | $25.80M |
| Pre-tax income | $27.60M | $9.50M | $58.90M | $29.00M | $72.20M | $35.80M | -$700.0K | -$7.00M | $27.00M | $9.90M | $14.30M | $5.00M |
| Income tax | $6.50M | $13.60M | $14.80M | $2.60M | $26.70M | $12.30M | -$700.0K | -$21.60M | $12.30M | -$19.00M | -$5.80M | -$1.00M |
| Net income | $21.10M | -$4.10M | $44.10M | $26.40M | $45.50M | $23.50M | $0 | $14.60M | $14.70M | $28.90M | $20.10M | $6.00M |
| EPS, basic | $0.36 | -$0.07 | $0.75 | $0.46 | $0.78 | $0.40 | $0.00 | $0.26 | $0.25 | $0.50 | $0.35 | $0.10 |
| EPS, diluted | $0.36 | -$0.07 | $0.74 | $0.44 | $0.78 | $0.40 | $0.00 | $0.24 | $0.25 | $0.50 | $0.35 | $0.11 |
| Diluted shares | 58.5M | 59.3M | 59.3M | - | 58.5M | 58.5M | 58.6M | - | 57.8M | 57.8M | 57.6M | - |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $214.70M | $184.90M | $201.30M | $225.50M | $233.60M | $212.30M | $216.70M | $274.20M | $281.80M | $306.50M | $298.70M | $326.50M |
| Receivables | $182.20M | $147.10M | $159.20M | $145.60M | $182.80M | $185.60M | $180.90M | $193.00M | $171.80M | $123.70M | $96.10M | $16.70M |
| Inventory | $214.20M | $192.60M | $181.80M | $178.60M | $189.90M | $169.20M | $169.10M | $171.50M | $185.60M | $153.20M | $149.20M | $152.10M |
| Current assets | $705.10M | $608.10M | $620.20M | $631.40M | $681.50M | $643.40M | $667.20M | $761.00M | $781.10M | $710.00M | $719.50M | $749.10M |
| Goodwill | $39.90M | $15.40M | $15.40M | $15.40M | $15.40M | $15.50M | $15.50M | $15.60M | $15.50M | $15.50M | $15.50M | $15.60M |
| Total assets | $1.27B | $1.03B | $1.06B | $1.09B | $1.16B | $1.12B | $1.15B | $1.29B | $1.27B | $1.20B | $1.22B | $1.21B |
| Current liabilities | $419.80M | $247.30M | $234.70M | $261.50M | $275.50M | $259.30M | $298.20M | $374.00M | $370.70M | $310.40M | $326.60M | $353.50M |
| Short-term debt | $139.40M | $9.50M | $9.50M | $9.50M | $9.50M | $9.50M | $9.50M | $9.50M | $9.50M | $9.50M | $9.50M | $9.50M |
| Long-term debt | $1.32B | $1.32B | $1.35B | $1.39B | $1.46B | $1.51B | $1.53B | $1.57B | $1.59B | $1.59B | $1.59B | $1.59B |
| Total debt | $1.46B | $1.33B | $1.36B | $1.40B | $1.47B | $1.52B | $1.54B | $1.57B | $1.60B | $1.60B | $1.60B | $1.60B |
| Shareholders' equity | -$612.70M | -$626.10M | -$613.10M | -$650.60M | -$669.60M | -$736.20M | -$768.80M | -$738.30M | -$763.70M | -$769.60M | -$793.50M | -$821.70M |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $41.80M | $31.10M | $17.20M | $84.00M | $81.20M | $31.80M | -$5.30M | $26.60M | -$2.10M | $24.30M | -$13.10M | $29.60M |
| Capital expenditures | $1.10M | $500.0K | $600.0K | $7.30M | $400.0K | $100.0K | $1.50M | $0 | $9.70M | $3.40M | $2.70M | $9.20M |
| Free cash flow | $40.70M | $30.60M | $16.60M | $76.70M | $80.80M | $31.70M | -$6.80M | $26.60M | -$11.80M | $20.90M | -$15.80M | $20.40M |
| Investing cash flow | -$129.50M | -$500.0K | $9.50M | -$7.30M | -$400.0K | -$100.0K | -$1.50M | $0 | -$9.70M | -$3.40M | -$2.70M | -$9.20M |
| Financing cash flow | $112.40M | -$41.50M | -$51.60M | -$81.60M | -$62.60M | -$37.30M | -$45.20M | -$36.60M | -$11.50M | -$11.80M | -$13.50M | -$9.70M |
| Dividends paid | $600.0K | $8.90M | $8.90M | $8.80M | $8.70M | $8.70M | $8.80M | $8.70M | $8.60M | $8.60M | $8.60M | $8.60M |
| Stock-based compensation | $4.20M | $5.70M | $5.90M | $9.50M | $5.90M | $7.30M | $8.90M | $6.20M | $6.30M | $6.50M | $7.30M | $4.90M |
| Depreciation and amortization | $10.60M | $10.20M | $10.30M | $13.10M | $9.20M | $9.00M | $9.40M | $9.50M | $8.90M | $9.00M | $8.80M | $9.30M |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -8.1% | -14.4% | -0.3% | -7.7% | 8.4% | -9.8% | -5.6% | 1.5% | -4.8% | 3.6% | 0.6% | 2.7% |
| Net income growth, YoY | -53.6% | - | - | 80.8% | 209.5% | -18.7% | -100.0% | 143.3% | -3.3% | 106.4% | -42.9% | - |
| EPS growth, YoY | -53.8% | - | - | 83.3% | 212.0% | -20.0% | -100.0% | 118.2% | -3.8% | 108.3% | -42.6% | - |
| Gross margin | 56.4% | 57.6% | 61.9% | 60.0% | 66.7% | 63.4% | 60.0% | 60.7% | 69.8% | 64.6% | 67.0% | 64.5% |
| Operating margin | 17.9% | 15.8% | 31.9% | 21.4% | 31.8% | 24.3% | 11.0% | 9.2% | 20.5% | 13.6% | 16.4% | 9.2% |
| Net margin | 7.8% | -1.8% | 16.9% | 10.0% | 15.4% | 9.1% | 0.0% | 5.1% | 5.4% | 10.1% | 7.2% | 2.1% |
| Free cash flow margin | 15.0% | 13.8% | 6.4% | 29.1% | 27.3% | 12.2% | -2.6% | 9.3% | -4.3% | 7.3% | -5.7% | 7.2% |
| Current ratio | 1.68 | 2.46 | 2.64 | 2.41 | 2.47 | 2.48 | 2.24 | 2.03 | 2.11 | 2.29 | 2.20 | 2.12 |
Source: XBRL data Embecta Corp. files with the SEC, latest filing dated Aug 7, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| EMBC | $1.02B | -7.6% | $87.50M | 8.6% | $350.7M |
| SYK | $26.30B | +7.9% | $3.62B | 13.8% | $124.05B |
| MMM | $25.25B | +1.7% | $3.54B | 14.0% | $95.67B |
| BSX | $21.07B | +8.9% | $3.50B | 16.6% | $61.96B |
| BDX | $23.25B | +17.4% | $941.00M | 4.0% | $57.71B |
| MDLN | $30.68B | - | $683.00M | 2.2% | $52.13B |
| RMD | $5.73B | +9.0% | $1.59B | 27.8% | $33.10B |
| DXCM | $5.10B | +13.0% | $991.00M | 19.4% | $29.62B |
| WST | $3.40B | +12.6% | $638.90M | 18.8% | $27.85B |